Resources by service
EU Market Challenges
Having successfully partnered in the launch of 15 significant orphan and niche drug products into the EU market over the last 3 years, Almac have witnessed a steady increase in the number of U.S. companies taking advantage of European Market Opportunities and expect this trend to increase.
In this article by Michael Rooney, Senior Business Support Manager at Almac, explores the European marketplace and how it presents a variety of challenges, from complex regulatory frameworks to numerous official working languages and varying country supply chain conditions.
Having supported a range of US clients in their EU launch from as far as 24 months before submission of their MAA to those with shorter time frames, post submission, Michael explains that it’s never too early to start to think about your pharmaceutical product launch. To gain more insight into the EU market, submit your details below:
*By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to firstname.lastname@example.org. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.